Search research articles
Contact Us
Filters
Showing results (991-1000 of 1,099) with videos related to
Page
of 110
Sort By:
Chemico-Biological Interactions
|
May 29, 2020
3,3',5,5'-tetramethoxybiphenyl-4,4'diol induces cell cycle arrest in G2/M phase and apoptosis in human non-small cell lung cancer A549 cells
Virginia Marcia Concato, Fernanda Tomiotto-Pellissier, Taylon Felipe Silva, et al.
Fitoterapia
|
May 27, 2018
Dehydroabietic acid isolated from Pinus elliottii exerts in vitro antileishmanial action by pro-oxidant effect, inducing ROS production in promastigote and downregulating Nrf2/ferritin expression in amastigote forms of Leishmania amazonensis
Manoela Daiele Gonçalves, B T S Bortoleti, Fernanda Tomiotto-Pellissier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer
Aditya Bardia, Sheng Sun, Nayana Thimmiah, et al.
Molecules (Basel, Switzerland)
|
October 6, 2020
Medicinal Potential of <i>Garcinia</i> Species and Their Compounds
Bruna Larissa Spontoni do Espirito Santo, Lidiani Figueiredo Santana, Wilson Hino Kato Junior, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 11, 2022
Clinical relevance of double-arm blood pressure measurement and prevalence of clinically important inter-arm blood pressure differences in Indian primary care
Gurpreet S Wander, Sinead T J McDonagh, M Srinivasa Rao, et al.
Chemico-Biological Interactions
|
October 12, 2021
Investigation of the antileishmanial activity and mechanisms of action of acetyl-thiohydantoins
Bruna Taciane da Silva Bortoleti, Manoela Daiele Gonçalves, Fernanda Tomiotto-Pellissier, et al.
NPJ Breast Cancer
|
January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)
Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
June 29, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
Antonino Glaviano, Seth A Wander, Richard D Baird, et al.
Frontiers in Cellular and Infection Microbiology
|
October 6, 2023
Exploring the leishmanicidal potential of terpenoids: a comprehensive review on mechanisms of cell death
Ana Carolina Jacob Rodrigues, Amanda Cristina Machado Carloto, Manoela Daiele Gonçalves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 18, 2024
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial
Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, et al.
Page
of 110
Search research articles
Search
Showing results (991-1000 of 1,099) with videos related to
Sort By:
Page
of 110
Chemico-Biological Interactions
|
May 29, 2020
3,3',5,5'-tetramethoxybiphenyl-4,4'diol induces cell cycle arrest in G2/M phase and apoptosis in human non-small cell lung cancer A549 cells
Virginia Marcia Concato, Fernanda Tomiotto-Pellissier, Taylon Felipe Silva, et al.
Fitoterapia
|
May 27, 2018
Dehydroabietic acid isolated from Pinus elliottii exerts in vitro antileishmanial action by pro-oxidant effect, inducing ROS production in promastigote and downregulating Nrf2/ferritin expression in amastigote forms of Leishmania amazonensis
Manoela Daiele Gonçalves, B T S Bortoleti, Fernanda Tomiotto-Pellissier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer
Aditya Bardia, Sheng Sun, Nayana Thimmiah, et al.
Molecules (Basel, Switzerland)
|
October 6, 2020
Medicinal Potential of <i>Garcinia</i> Species and Their Compounds
Bruna Larissa Spontoni do Espirito Santo, Lidiani Figueiredo Santana, Wilson Hino Kato Junior, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 11, 2022
Clinical relevance of double-arm blood pressure measurement and prevalence of clinically important inter-arm blood pressure differences in Indian primary care
Gurpreet S Wander, Sinead T J McDonagh, M Srinivasa Rao, et al.
Chemico-Biological Interactions
|
October 12, 2021
Investigation of the antileishmanial activity and mechanisms of action of acetyl-thiohydantoins
Bruna Taciane da Silva Bortoleti, Manoela Daiele Gonçalves, Fernanda Tomiotto-Pellissier, et al.
NPJ Breast Cancer
|
January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)
Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
June 29, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
Antonino Glaviano, Seth A Wander, Richard D Baird, et al.
Frontiers in Cellular and Infection Microbiology
|
October 6, 2023
Exploring the leishmanicidal potential of terpenoids: a comprehensive review on mechanisms of cell death
Ana Carolina Jacob Rodrigues, Amanda Cristina Machado Carloto, Manoela Daiele Gonçalves, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 18, 2024
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial
Kevin Kalinsky, Giampaolo Bianchini, Erika Hamilton, et al.
Page
of 110